A Single-Dose, Open-Label, Randomized, Parallel-Group Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Paliperidone Palmitate 3-Month Formulation in Subjects With Schizophrenia
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008736/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess the pharmacokinetics, safety, and tolerability of a
paliperidone palmitate 3-month formulation in patients with schizophrenia.
提供机构：
Vivli
创建时间：
2023-01-19
